itraconazole and Hepatic Failure

itraconazole has been researched along with Hepatic Failure in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Igawa, Y; Ishizuka, H; Ishizuka, T; Shimizu, T; Watanabe, A; Yamada, M1
Ben-Ami, R; Brenner, S; Levtov, S; Srebrnik, A1

Trials

1 trial(s) available for itraconazole and Hepatic Failure

ArticleYear
Physiologically based pharmacokinetic modelling to predict the clinical effect of CYP3A inhibitors/inducers on esaxerenone pharmacokinetics in healthy subjects and subjects with hepatic impairment.
    European journal of clinical pharmacology, 2022, Volume: 78, Issue:1

    Topics: Antihypertensive Agents; Area Under Curve; Computer Simulation; Cytochrome P-450 CYP3A Inducers; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Healthy Volunteers; Humans; Itraconazole; Japan; Liver Failure; Metabolic Clearance Rate; Models, Biological; Pyrroles; Rifampin; Sulfones

2022

Other Studies

1 other study(ies) available for itraconazole and Hepatic Failure

ArticleYear
Liver failure and transplantation after itraconazole treatment for toenail onychomycosis.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2005, Volume: 19, Issue:2

    Topics: Adult; Antifungal Agents; Female; Foot Dermatoses; Humans; Itraconazole; Liver Failure; Liver Function Tests; Liver Transplantation; Onychomycosis

2005